ERAMET (ER7.DE) Stock Fundamental Analysis
Europe - FRA:ER7 - FR0000131757 - Common Stock
60.05 EUR
-0.05 (-0.08%)
Taking everything into account, ER7 scores 3 out of 10 in our fundamental rating. ER7 was compared to 42 industry peers in the Metals & Mining industry. ER7 has a bad profitability rating. Also its financial health evaluation is rather negative. ER7 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ER7 had negative earnings in the past year.
In the past year ER7 has reported a negative cash flow from operations.
Of the past 5 years ER7 4 years were profitable.
ER7 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a Return On Assets value of -1.58%, ER7 is not doing good in the industry: 62.79% of the companies in the same industry are doing better.
ER7's Return On Equity of -9.29% is on the low side compared to the rest of the industry. ER7 is outperformed by 67.44% of its industry peers.
ER7's Return On Invested Capital of 0.80% is on the low side compared to the rest of the industry. ER7 is outperformed by 69.77% of its industry peers.
ER7 had an Average Return On Invested Capital over the past 3 years of 7.29%. This is in line with the industry average of 7.74%.
The last Return On Invested Capital (0.80%) for ER7 is well below the 3 year average (7.29%), which needs to be investigated, but indicates that ER7 had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.58% | ||
| ROE | -9.29% | ||
| ROIC | 0.8% |
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.29%
ROIC(5y)7.73%
1.3 Margins
In the last couple of years the Profit Margin of ER7 has declined.
ER7 has a Operating Margin of 1.91%. This is in the lower half of the industry: ER7 underperforms 67.44% of its industry peers.
In the last couple of years the Operating Margin of ER7 has declined.
ER7 has a better Gross Margin (68.15%) than 93.02% of its industry peers.
ER7's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.91% | ||
| PM (TTM) | N/A | ||
| GM | 68.15% |
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
2. Health
2.1 Basic Checks
ER7 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ER7 has more shares outstanding than it did 1 year ago.
ER7 has more shares outstanding than it did 5 years ago.
ER7 has a better debt/assets ratio than last year.
2.2 Solvency
ER7 has an Altman-Z score of 1.11. This is a bad value and indicates that ER7 is not financially healthy and even has some risk of bankruptcy.
ER7 has a worse Altman-Z score (1.11) than 76.74% of its industry peers.
ER7 has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
ER7 has a worse Debt to Equity ratio (2.03) than 88.37% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.11 |
ROIC/WACC0.09
WACC9.1%
2.3 Liquidity
ER7 has a Current Ratio of 1.54. This is a normal value and indicates that ER7 is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ER7 (1.54) is worse than 69.77% of its industry peers.
A Quick Ratio of 1.06 indicates that ER7 should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.06, ER7 perfoms like the industry average, outperforming 48.84% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.54 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
The earnings per share for ER7 have decreased strongly by -221.18% in the last year.
The earnings per share for ER7 have been decreasing by -64.00% on average. This is quite bad
Looking at the last year, ER7 shows a decrease in Revenue. The Revenue has decreased by -6.91% in the last year.
Measured over the past years, ER7 shows a decrease in Revenue. The Revenue has been decreasing by -4.39% on average per year.
EPS 1Y (TTM)-221.18%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%
3.2 Future
The Earnings Per Share is expected to grow by 10.10% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.46% on average over the next years. This is quite good.
EPS Next Y-283.87%
EPS Next 2Y27.79%
EPS Next 3Y10.1%
EPS Next 5YN/A
Revenue Next Year6.09%
Revenue Next 2Y7.62%
Revenue Next 3Y8.46%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
ER7 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
ER7 is valuated reasonably with a Price/Forward Earnings ratio of 8.76.
86.05% of the companies in the same industry are more expensive than ER7, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, ER7 is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 8.76 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ER7 is valued a bit more expensive than 60.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 15.75 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.79%
EPS Next 3Y10.1%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.25%, ER7 has a reasonable but not impressive dividend return.
ER7's Dividend Yield is a higher than the industry average which is at 2.61.
ER7's Dividend Yield is comparable with the S&P500 average which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.25% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
The earnings of ER7 are negative and hence is the payout ratio. ER7 will probably not be able to sustain this dividend level.
DP-44.33%
EPS Next 2Y27.79%
EPS Next 3Y10.1%
FRA:ER7 (10/24/2025, 7:00:00 PM)
60.05
-0.05 (-0.08%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners12.66%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.73B
Revenue(TTM)2.88B
Net Income(TTM)-97000000
Analysts52.73
Price Target52.13 (-13.19%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.25% |
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP-44.33%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.12%
PT rev (3m)-20.02%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-535.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.69%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 8.76 | ||
| P/S | 0.6 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.65 | ||
| P/tB | 3.2 | ||
| EV/EBITDA | 15.75 |
EPS(TTM)-3.44
EYN/A
EPS(NY)6.85
Fwd EY11.41%
FCF(TTM)-25.76
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS100.31
BVpS36.3
TBVpS18.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.58% | ||
| ROE | -9.29% | ||
| ROCE | 1.16% | ||
| ROIC | 0.8% | ||
| ROICexc | 0.95% | ||
| ROICexgc | 1.09% | ||
| OM | 1.91% | ||
| PM (TTM) | N/A | ||
| GM | 68.15% | ||
| FCFM | N/A |
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.29%
ROIC(5y)7.73%
ROICexc(3y)10.98%
ROICexc(5y)11.38%
ROICexgc(3y)12.91%
ROICexgc(5y)13.43%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexgc growth 3Y-56.22%
ROICexgc growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 10.29 | ||
| Cap/Depr | 403.31% | ||
| Cap/Sales | 21.11% | ||
| Interest Coverage | 0.34 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.54 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z | 1.11 |
F-Score2
WACC9.1%
ROIC/WACC0.09
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.18%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
EPS Next Y-283.87%
EPS Next 2Y27.79%
EPS Next 3Y10.1%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%
Revenue Next Year6.09%
Revenue Next 2Y7.62%
Revenue Next 3Y8.46%
Revenue Next 5YN/A
EBIT growth 1Y-51.75%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year19.46%
EBIT Next 3Y25.5%
EBIT Next 5YN/A
FCF growth 1Y-850%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.46%
OCF growth 3YN/A
OCF growth 5YN/A
ERAMET / ER7.DE FAQ
What is the fundamental rating for ER7 stock?
ChartMill assigns a fundamental rating of 3 / 10 to ER7.DE.
What is the valuation status for ER7 stock?
ChartMill assigns a valuation rating of 2 / 10 to ERAMET (ER7.DE). This can be considered as Overvalued.
What is the profitability of ER7 stock?
ERAMET (ER7.DE) has a profitability rating of 3 / 10.
How financially healthy is ERAMET?
The financial health rating of ERAMET (ER7.DE) is 2 / 10.
Can you provide the dividend sustainability for ER7 stock?
The dividend rating of ERAMET (ER7.DE) is 2 / 10 and the dividend payout ratio is -44.33%.